Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Stock Analysis

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) is a publicly traded company in the HEALTHCARE sector. It trades at $0.30. This page summarizes the public market data, fundamentals, and frequently asked questions for PTHL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $0.30

About Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd Class A Ordinary Shares is a pioneering healthcare technology company dedicated to transforming cancer treatment through its innovative software and devices for brachytherapy, a targeted form of radiation therapy. With a strong emphasis on research and development, Pheton is committed to enhancing patient outcomes by delivering precise and efficient therapeutic solutions. Positioned strategically within the expanding healthcare sector, the company aims to leverage the incr...

GNG Research Analysis

GNG Research scores Pheton Holdings Ltd Class A Ordinary Shares (PTHL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PTHL.

Frequently Asked Questions

Does PTHL pay dividends?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) does not currently pay a regular dividend.